SCHEMBL21941663

SCHEMBL21941663

CCCC(CCn1c(=O)sc2c(=O)[nH]c(N)nc21)OC

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 19/20 0.46
PNP P00491 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338431 0.78 PNP (0.61) TLR7PNP
SCHEMBL13851087 0.77 HPGD (0.51) TLR7PNP
SCHEMBL22911737 0.75 TLR7 (0.46) TLR7
SCHEMBL8437308 0.72 TK1 (0.51) TLR7PNP
SCHEMBL8438778 0.71 TLR7 (0.43) TLR7
SCHEMBL8440066 0.71 PNP (0.41) TLR7PNP
SCHEMBL8437638 0.71 PNP (0.44) TLR7PNP
SCHEMBL8439273 0.71 TLR7 (0.43) TLR7
SCHEMBL8435553 0.71 TLR7 (0.43) TLR7
SCHEMBL8435556 0.71 TLR7 (0.43) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3270915-B1 COMBINED TREATMENT WITH A TLR7 AGONIST AND AN HBV CAPSID ASSEMBLY INHIBITOR HOFFMANN LA ROCHE (CH) 2020-04-15 EP disclosed